University of Cambridge > > Institute for Energy and Environmental Flows (IEEF) > PlaqueTec Limited

PlaqueTec Limited

Add to your list(s) Download to your calendar using vCal

If you have a question about this talk, please contact Catherine Pearson.

Based in the UK’s leading cardiology hospital, PlaqueTec is a start-up within the Cambridge Biotechnology cluster. PlaqueTec’s novel device measures intracoronary biomarker gradients in a manner that negates patient to patient variation. For the first time, this offers the potential to gather actionable data for surrogate end points, and potential new druggable targets for atherosclerosis and Cardiovascular Disease (CVD). PlaqueTec is nearing completion of its device development and is about to commence its Biomarker Discovery Program. Joe Corrigan, head of the device research programme at PlaqueTec, will present an overview of the state of the art in CVD diagnosis and the background to the PlaqueTec device.

This talk is part of the Institute for Energy and Environmental Flows (IEEF) series.

Tell a friend about this talk:

This talk is included in these lists:

Note that ex-directory lists are not shown.


© 2006-2024, University of Cambridge. Contact Us | Help and Documentation | Privacy and Publicity